Source: Current Drug Safety. Unidade: FCF
Subjects: LEUCEMIA, QUIMIOTERAPIA
ABNT
PEREZ, Maria MargaritaTosta et al. Posterior reversible encephalopathy syndrome associated with L-Asparaginase treatment in children: literature review and six case reports. Current Drug Safety, v. 20, n. 3, p. 311-322, 2025Tradução . . Disponível em: https://dx.doi.org/10.2174/0115748863290290240710161133. Acesso em: 22 jul. 2025.APA
Perez, M. M. T., Belen, L. H., Pessoa Junior, A., & Avendano, J. F. (2025). Posterior reversible encephalopathy syndrome associated with L-Asparaginase treatment in children: literature review and six case reports. Current Drug Safety, 20( 3), 311-322. doi:10.2174/0115748863290290240710161133NLM
Perez MMT, Belen LH, Pessoa Junior A, Avendano JF. Posterior reversible encephalopathy syndrome associated with L-Asparaginase treatment in children: literature review and six case reports [Internet]. Current Drug Safety. 2025 ; 20( 3): 311-322.[citado 2025 jul. 22 ] Available from: https://dx.doi.org/10.2174/0115748863290290240710161133Vancouver
Perez MMT, Belen LH, Pessoa Junior A, Avendano JF. Posterior reversible encephalopathy syndrome associated with L-Asparaginase treatment in children: literature review and six case reports [Internet]. Current Drug Safety. 2025 ; 20( 3): 311-322.[citado 2025 jul. 22 ] Available from: https://dx.doi.org/10.2174/0115748863290290240710161133